UK M&A deals of the week: 17 October 2025

UK M&A deals of the week: 17 October 2025

This week’s M&A activity spanned industrials, logistics, infrastructure, and professional services. From a £1.3 billion carve-out in manufacturing to a landmark logistics portfolio transfer, the UK remained a focal point for global buyers refining strategy, scale, and sector exposure.







This week’s M&A activity highlights how investors are repositioning around certainty, scale, and strategic focus. Portfolio refinement remains a core theme: Smiths Group’s sale to Molex mirrors a wider industrial trend toward concentrating on fewer, higher-margin divisions. Meanwhile, the Tritax and Macquarie transactions show the persistent pull of UK hard assets for long-term capital — even as borrowing costs remain elevated. Both deals demonstrate how global investors are seeking dependable yield through physical infrastructure rather than cyclical equities.

In technology and professional services, the acquisition of Decho by Accenture and SRG’s dual healthcare deals illustrate how specialist UK firms continue to command premium valuations from international buyers. These transactions are being driven by capability, not scale — signalling that the UK’s value proposition increasingly lies in deep technical expertise and regulated-market know-how.

Overall, deal flow across the week suggests that, despite economic caution, buyers are targeting assets offering either resilience through essential infrastructure or strategic leverage through specialisation. The market remains globally active, but increasingly selective — focusing on businesses that deliver structural certainty in uncertain conditions.

  • Strategic concentration — UK industrials are streamlining portfolios to drive clarity and profitability, as seen in Smiths Group’s divestment to Molex.
  • Infrastructure resilience — Real-asset investment continues to attract global capital, with Tritax and Macquarie reinforcing confidence in UK logistics and aviation.
  • Specialist expertise premium — Deals in AI consultancy and healthcare insurance show that international acquirers are paying for deep technical and regulatory expertise rather than broad market exposure.

Stay ahead of the curve with Business Quarter’s weekly M&A briefing, a concise, authoritative roundup of the biggest deals, strategic plays, and market-moving partnerships.

Sign up now to get each week’s summary straight to your inbox.

← Back

Thank you for your response. ✨



  • Foreverland raises €6m for Europe push

    Foreverland raises €6m for Europe push

    Foreverland is scaling cocoa-free chocolate across Europe after fresh funding. The Italian foodtech company has raised €6 million to expand Choruba, deepen manufacturer partnerships, and support a new organic product line.


  • Durham study exposes multiple-job protection gaps

    Durham study exposes multiple-job protection gaps

    Multiple-job workers face widening gaps in dignity protections at work. New research argues current frameworks miss the realities of precarious multiple employment, leaving essential workers exposed to stress, stigma, and weak workplace protections.


  • New training targets autoimmune workplace blind spot

    New training targets autoimmune workplace blind spot

    Autoimmune illness is emerging as a major workplace risk nationwide. A new CPD-accredited training programme is aiming to help employers and healthcare professionals recognise autoimmune disease earlier and respond with more effective support.